Roy Kishony

17.3k total citations · 7 hit papers
83 papers, 10.5k citations indexed

About

Roy Kishony is a scholar working on Genetics, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Roy Kishony has authored 83 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Genetics, 33 papers in Molecular Biology and 23 papers in Molecular Medicine. Recurrent topics in Roy Kishony's work include Evolution and Genetic Dynamics (42 papers), Antibiotic Resistance in Bacteria (23 papers) and Bacterial Genetics and Biotechnology (13 papers). Roy Kishony is often cited by papers focused on Evolution and Genetic Dynamics (42 papers), Antibiotic Resistance in Bacteria (23 papers) and Bacterial Genetics and Biotechnology (13 papers). Roy Kishony collaborates with scholars based in United States, Israel and Austria. Roy Kishony's co-authors include Remy Chait, Michael Baym, Idan Yelin, Tami D. Lieberman, Eric D. Kelsic, Matthew Hegreness, Adam C. Palmer, Pamela J. Yeh, Daniel L. Hartl and Noam Shoresh and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Roy Kishony

83 papers receiving 10.3k citations

Hit Papers

Evolutionary paths to ant... 2011 2026 2016 2021 2011 2015 2015 2016 2021 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Roy Kishony 4.9k 3.8k 2.0k 1.5k 1.2k 83 10.5k
Bruce R. Levin 4.7k 1.0× 6.4k 1.7× 3.1k 1.6× 1.8k 1.2× 4.2k 3.5× 159 15.6k
Morten Otto Alexander Sommer 5.2k 1.1× 1.6k 0.4× 2.8k 1.4× 1.1k 0.7× 1.3k 1.1× 159 10.0k
Olivier Tenaillon 3.6k 0.7× 3.8k 1.0× 1.2k 0.6× 693 0.5× 994 0.8× 92 7.2k
R. Craig MacLean 2.7k 0.6× 2.9k 0.8× 2.0k 1.0× 447 0.3× 1.5k 1.2× 97 6.5k
Otto G. Berg 9.5k 1.9× 3.8k 1.0× 1.4k 0.7× 377 0.3× 1.3k 1.0× 120 13.0k
Sebastian Bonhoeffer 3.9k 0.8× 4.9k 1.3× 1.2k 0.6× 6.1k 4.1× 997 0.8× 233 21.2k
Nicholas R. Thomson 4.8k 1.0× 2.3k 0.6× 3.7k 1.9× 2.8k 1.9× 2.9k 2.4× 308 14.4k
Remy Chait 2.6k 0.5× 2.3k 0.6× 1.2k 0.6× 468 0.3× 642 0.5× 22 4.8k
João B. Xavier 6.1k 1.2× 1.8k 0.5× 417 0.2× 2.1k 1.4× 1.3k 1.0× 98 10.0k
François Taddéi 4.4k 0.9× 3.8k 1.0× 662 0.3× 394 0.3× 1.2k 1.0× 76 7.3k

Countries citing papers authored by Roy Kishony

Since Specialization
Citations

This map shows the geographic impact of Roy Kishony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Kishony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Kishony more than expected).

Fields of papers citing papers by Roy Kishony

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Kishony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Kishony. The network helps show where Roy Kishony may publish in the future.

Co-authorship network of co-authors of Roy Kishony

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Kishony. A scholar is included among the top collaborators of Roy Kishony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Kishony. Roy Kishony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hafner, Lukas, et al.. (2024). Autonomous LLM-Driven Research — from Data to Human-Verifiable Research Papers. NEJM AI. 2(1). 13 indexed citations
2.
Yelin, Idan, et al.. (2024). Beta-lactamase dependent and independent evolutionary paths to high-level ampicillin resistance. Nature Communications. 15(1). 5383–5383. 9 indexed citations
3.
Yelin, Idan, et al.. (2023). Systematic identification of gene-altering programmed inversions across the bacterial domain. Nucleic Acids Research. 51(2). 553–573. 6 indexed citations
4.
Stracy, Mathew, Olga Snitser, Idan Yelin, et al.. (2022). Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections. Science. 375(6583). 889–894. 205 indexed citations breakdown →
5.
Gupta, Animesh, Luis Zaman, Jenna Gallie, et al.. (2022). Host-parasite coevolution promotes innovation through deformations in fitness landscapes. eLife. 11. 14 indexed citations
6.
Levine-Tiefenbrun, Matan, Idan Yelin, Jacob Kuint, et al.. (2021). SARS-CoV-2 RT-qPCR Test Detection Rates Are Associated with Patient Age, Sex, and Time since Diagnosis. Journal of Molecular Diagnostics. 24(2). 112–119. 8 indexed citations
7.
Levine-Tiefenbrun, Matan, Idan Yelin, Hillel Alapi, et al.. (2021). Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2. Nature Medicine. 27(12). 2108–2110. 139 indexed citations
8.
Yelin, Idan, Einat Shaer Tamar, Amir Argoetti, et al.. (2020). Evaluation of COVID-19 RT-qPCR Test in Multi sample Pools. Clinical Infectious Diseases. 71(16). 2073–2078. 248 indexed citations
9.
Ershov, Dmitry, Noreen Walker, Daniel Schultz, et al.. (2018). Size Laws and Division Ring Dynamics in Filamentous Escherichia coli cells. Current Biology. 28(6). 972–979.e5. 70 indexed citations
10.
Baym, Michael, et al.. (2015). Multidrug evolutionary strategies to reverse antibiotic resistance. Science. 351(6268). aad3292–aad3292. 496 indexed citations breakdown →
11.
Yao, Zhizhong, Rebecca Davis, Roy Kishony, Daniel Kahne, & Natividad Ruiz. (2012). Regulation of cell size in response to nutrient availability by fatty acid biosynthesis in Escherichia coli. Proceedings of the National Academy of Sciences. 109(38). E2561–8. 131 indexed citations
12.
Palmer, Adam C., Erdal Toprak, Seungsoo Kim, et al.. (2012). Mutational pathways to drug resistance through a maximally-rugged fitness landscape. Bulletin of the American Physical Society. 2012. 1 indexed citations
13.
Yao, Zhizhong, Daniel Kahne, & Roy Kishony. (2012). Distinct Single-Cell Morphological Dynamics under Beta-Lactam Antibiotics. Molecular Cell. 48(5). 705–712. 156 indexed citations
14.
Palmer, Adam C., Elaine Angelino, & Roy Kishony. (2010). Chemical decay of an antibiotic inverts selection for resistance. Nature Chemical Biology. 6(2). 105–107. 76 indexed citations
15.
Swoboda, Jonathan G., Timothy C. Meredith, Jennifer Campbell, et al.. (2009). Discovery of a Small Molecule that Blocks Wall Teichoic Acid Biosynthesis in Staphylococcus aureus. ACS Chemical Biology. 4(10). 875–883. 116 indexed citations
16.
Michel, Jean-Baptiste, Pamela J. Yeh, Remy Chait, Robert C. Moellering, & Roy Kishony. (2008). Drug interactions modulate the potential for evolution of resistance. Proceedings of the National Academy of Sciences. 105(39). 14918–14923. 170 indexed citations
17.
Bollenbach, Tobias, Kalin Vetsigian, & Roy Kishony. (2007). Evolution and multilevel optimization of the genetic code. Genome Research. 17(4). 401–404. 32 indexed citations
18.
Hegreness, Matthew, Noam Shoresh, Daniel L. Hartl, & Roy Kishony. (2006). An Equivalence Principle for the Incorporation of Favorable Mutations in Asexual Populations. Science. 311(5767). 1615–1617. 185 indexed citations
19.
Kussell, Edo, Roy Kishony, Nathalie Q. Balaban, & Stanislas Leibler. (2005). Bacterial Persistence. Genetics. 169(4). 1807–1814. 413 indexed citations
20.
Segrè, Daniel, Alexander DeLuna, George M. Church, & Roy Kishony. (2004). Modular epistasis in yeast metabolism. Nature Genetics. 37(1). 77–83. 451 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026